Numerous studies have shown that excessive activation of the NLRP3 inflammasome causes multiple autoinflammatory and autoimmune-associated metabolic disorders, including gout, type 2 diabetes, Alzheimer’s disease, atherosclerosis and cryopyrin-associated periodic syndromes (CAPS) (5–8). This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.